Academic Journal
Q2Pharmacia
About Pharmacia
Pharmacia is a scholarly journal published by Pensoft Publishers. SCImago 2025 lists it in Q2, with an SJR of 0.334 and H-index of 26.
Coverage: 1945, 1954-1955, 1987-1991, 1997-2026. Research categories: Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-04-03. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Pharmaceutical Practices and Patient Outcomes; Computational Drug Discovery Methods; Essential Oils and Antimicrobial Activity; Synthesis and biological activity; Phytochemistry and Biological Activities; Phytochemicals and Antioxidant Activities.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Exploratory cost-utility and cost-effectiveness analysis of venetoclax plus azacitidine vs. azacitidine monotherapy in Bulgarian patients with AML ineligible for intensive chemotherapy: a real-world-data-influenced state-occupancy model
Martin Donchev, Yanitsa Davidkova, Konstantin Tachkov, Guenka Petrova et al.
2026-09-29 · DOI: 10.3897/pharmacia.73.e197277Comparative molecular docking and ADMET profiling of niclosamide and berberine against multiple Helicobacter pylori enzymatic targets
Catalina Danila, Lucian Faur, Lucian Mocan, Daniela Simona Cavalu et al.
2026-09-29 · DOI: 10.3897/pharmacia.73.e212118Parallel multi-response optimization of reflux and maceration extraction of Sargassum polycystum from the east coast of Pangandaran using Box–Behnken design
Susanti Susanti, Aiman Fisabilah, Insan Kamil, Salsabila Adlina et al.
2026-09-28 · DOI: 10.3897/pharmacia.73.e209685Antibacterial activity, molecular docking, and in silico safety profiling of novel 3,10-dihydro-2H-1,3-oxazepino[7,6-b]indole derivatives
Mervat S. Sammor, Marwan M. Abu-Halaweh, Khadeejha Al Abrouni, Balakumar Chandrasekaran et al.
2026-09-28 · DOI: 10.3897/pharmacia.73.e199777A comparative study of visual outcomes and patient satisfaction with Evolux™, monofocal, and extended depth of focus intraocular lenses
Yani Zdravkov, Radomir Dzhambazov, Nevyana Veleva, Vasil Haykin et al.
2026-09-25 · DOI: 10.3897/pharmacia.73.e200063Clinical pharmacist-led multiplex polymerase chain reaction diagnostics as a tool for antimicrobial stewardship in acute exacerbations of chronic obstructive pulmonary disease
Olivera Krstic Nakovska, Evgenija Mihajloska, Angjela Debreshlioska, Dimitar Karkinski et al.
2026-09-25 · DOI: 10.3897/pharmacia.73.e203025Detection of DRPs in geriatric patients with rare diseases: a systematic review and retrospective analysis
Aleksina Parvanova, Petya Milushewa, Konstantin Tachkov, Silvia Vandeva et al.
2026-09-24 · DOI: 10.3897/pharmacia.73.e201120Current drug treatment of mental disorders
Nurdana Bidan, Ubaidilla Datkhayev, Elmira Serikbayeva, Kairat Zhakipbekov et al.
2026-09-24 · DOI: 10.3897/pharmacia.73.e194894Technological approaches to tamoxifen nanoformulation: emphasis on modified chitosan-based nanoparticles: a review
Daniel Argilashki
2026-09-24 · DOI: 10.3897/pharmacia.73.e206326Investigation of lipophilicity of new stilbene derivatives with chromatographic and computational approaches
Stela Georgieva, Tsvetomil Voyslavov, Christo Chanev, Ognyan Petrov et al.
2026-09-21 · DOI: 10.3897/pharmacia.73.e200443Pharmacist-led deprescribing of potentially inappropriate medications in older adults in Saudi Arabia: a narrative review
Khalid A. Alamer, Fawaz M. Alotaibi
2026-09-21 · DOI: 10.3897/pharmacia.73.e211525Exploring benzofuran derivatives as selective MAO-B inhibitors: a multilayered in silico study
Emilio Mateev, Ali Irfan, Stefan Kostov, Muhammed Tilahun Muhammed et al.
2026-09-16 · DOI: 10.3897/pharmacia.73.e206275Rituximab therapy in severe PR3-ANCA pulmonary–renal syndrome: A clinical and pharmaceutical case report
Dimitar Nikolov, Georgi Nikolov, Lyudmila Kitova, Spas Kitov et al.
2026-09-16 · DOI: 10.3897/pharmacia.73.e201634Pharmacist intervention to improve medication adherence in patients with depressive disorder: A scoping review
Herda Ariyani, Chairun Wiedyaningsih, Raden Ajeng Yayi Suryo Prabandari, Sri Idaiani et al.
2026-09-15 · DOI: 10.3897/pharmacia.73.e178613Exploratory immunoinformatic and single-donor ex vivo evaluation of methicillin-resistant Staphylococcus aureus virulence-factor peptide combinations in burn-associated bacteraemia: Implications for MRSA vaccine development
Arviansyah, Sumarno, Edi Mustamsir, Irene Ratridewi et al.
2026-09-15 · DOI: 10.3897/pharmacia.73.e196054Animal study of the cardiovascular effects of tofacitinib: Hemodynamic, biochemical, vascular, and mortality outcomes
Antoan Rangelov, Iva Parvova, Emil Hristov, Georgi Momekov et al.
2026-09-15 · DOI: 10.3897/pharmacia.73.e206503Dispensing practices, knowledge gaps, and educational needs of community pharmacists in Jordan regarding the use of diabetes medications for weight management
Jumanah D. Al-Shawabkeh, Nidal M. F. Abulaban, Ali Ata Alsarhan, Laila Alsawalha et al.
2026-09-15 · DOI: 10.3897/pharmacia.73.e1979601,3,4-Oxadiazole derivatives as potential anti-glioma agents: synthesis, characterization, in vitro cytotoxic activity against HS683 cells, and molecular docking
Rabab Jameel Hashim, Hiba Najeh Alsaad, Husam Hamza Salman
2026-09-14 · DOI: 10.3897/pharmacia.73.e198079Occupational burnout as a workforce management challenge in Kazakhstan’s pharmacy sector
Syrym Jiyenbalanov, Assem Kalykova, Kairat Zhakipbekov, Naoko Arakawa et al.
2026-09-11 · DOI: 10.3897/pharmacia.73.e195725Analysis of direct medical costs for the treatment of peptic ulcer disease in inpatients at a military hospital: a retrospective study in Vietnam
The Due Ong, Vinh-Quang Tran, Phung Ngoc Minh Nguyen, Hieu Minh Nguyen et al.
2026-09-11 · DOI: 10.3897/pharmacia.73.e201763Reviews
Community Reviews
Version History
October 4, 2026 at 9:28 pm
October 2, 2026